As it has been demonstrated that not only T cells can be activated by IFNβ but also NK cell cytotoxicity [23,25], our analysis focused on the cytotoxic activity of NK cells against melanoma cells and how this process may be modulated by IFNβ and PD-L1/PD-1 checkpoint blockade. This evidence concerns the gene IFNB1 and melanoma.